- 1、本文档共61页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
院内耐多药革兰阴性菌感染治疗中的若干问题课件
* Acinetobacter Acinetobacter species are aerobic gram-negative bacteria that are widely distributed in soil and water and can occasionally be cultured from skin, mucous membranes, secretions, and the hospital environment.Acinetobacter baumannii is the species most commonly isolated. A baumannii has been isolated from blood, sputum, skin, pleural fluid, and urine, usually in device-associated infections. Acinetobacter encountered in nosocomial pneumonia often originates in the water of room humidifiers or vaporizers. In patients with acinetobacter bacteremia, intravenous catheters are almost always the source of infection. In patients with burns or with immune deficiencies, acinetobacter acts as an opportunistic pathogen and can produce sepsis. Acinetobacter strains are often resistant to antimicrobial agents, and therapy of infection can be difficult. Susceptibility testing should be done to help select the best antimicrobial drugs for therapy. Acinetobacter strains respond most commonly to gentamicin, amikacin, or tobramycin and to newer penicillins or cephalosporins. * 接下来我们一起来看一个荟萃分析,其中5个临床实验全部是比较单药与多药联合治疗铜绿假单胞菌感染的。如图所示,所有实验中的联合用药组死亡率都要低于单药治疗组10%-20%左右。 * * 下面我们一起来看一个美国和加拿大做的碳青霉烯联合喹诺酮治疗铜绿引起的VAP(呼吸机相关肺炎)的临床实验,结果显示,联合用药在各项指标(根据表格详述)均优于单药治疗! * Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients Wang Liang, et al BMC Infectious Diseases 2011, 11:109 A combination of meropenem (16 μg/mL) with minocycline (0.5×MIC, 4or 2 μg/mL) was synergitic to all test isolates, but neither showed bactericidal activity alone. combinations of colistin at 0.5×MIC (0.25 or 0.125 μg/mL) with each of the above were synergistic and shown bactericidal activities against all test isolates. The MST12h values of drug combinations (either colistin- or minocycline-based combinations) were significantly shorter than those of the single drugs (p 0.01). Conclusions: Conclusions: This
您可能关注的文档
- 问诊病史采集课件_1.ppt
- 问诊病史采集课件.ppt
- 问诊病史采集(课件幻灯).ppt
- 门诊罕见急症救治与心肺苏醒宝典课件.ppt
- 镇静镇痛ICU安全护理课件.ppt
- 问诊(Inquiry)病史采集课件.ppt
- 门店适销氛围营造标准柜台陈列规范讲解课件.ppt
- 阅读理解之猜词技巧专题讲解课件概要.ppt
- 问诊(Inquiry)病史采集课件_1.ppt
- 镇静镇痛课件_1.ppt
- 金融产品2024年投资策略报告:积极适应市场风格,行为金融+机器学习新发现.pdf
- 交运物流2024年度投资策略:转型十字路,峰回路又转(2023120317).pdf
- 建材行业2024年投资策略报告:板块持续磨底,重点关注需求侧复苏.pdf
- 宏观2024年投资策略报告:复苏之路.pdf
- 光储氢2024年投资策略报告:复苏在春季,需求的非线性增长曙光初现.pdf
- 公用环保2024年投资策略报告:电改持续推进,火电盈利稳定性有望进一步提升.pdf
- 房地产2024年投资策略报告:聚焦三大工程,静待需求修复.pdf
- 保险2024年投资策略报告:资产负债匹配穿越利率周期.pdf
- 政策研究2024年宏观政策与经济形势展望:共识与分歧.pdf
- 有色金属行业2024年投资策略报告:新旧需求共振&工业原料受限,构筑有色大海星辰.pdf
文档评论(0)